Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

pharma regulatory bodies in 2026: FDA, EMA, WHO Roles, and Global GMP Control Systems

This article explores how pharma regulatory bodies such as FDA, EMA, and WHO shape global GMP compliance. It highlights inspection trends, data integrity requirements, and harmonized regulatory frameworks that drive pharmaceutical quality systems and inspection readiness worldwide.
  • Blog, Validation and Qualification
Illustration of FDA, EMA, and WHO regulatory bodies overseeing global GMP inspection readiness, pharmaceutical quality systems, and data integrity requirements in international drug regulatory frameworks.

The Role of the EMA in Vaccine Approvals

In response to the COVID-19 pandemic, the European Medicines Agency (EMA) adapted its vaccine approval processes, implementing rolling reviews and enhancing collaboration with health authorities. This post analyzes the EMA's pivotal role in granting conditional marketing authorizations for COVID-19 vaccines
  • GxP, Quality Management System
Close up on vaccine and medical syringe

Getting Started with Process Validation

Learn the fundamental steps and best practices for successful Process Validation in manufacturing, covering design, qualification, and continuous monitoring to ensure product quality and compliance.
  • Blog, Process Validation

How Environmental Monitoring Enhances Product Quality

In the pharmaceutical industry, ensuring product quality is paramount. Rigorous environmental monitoring plays a critical role in maintaining this quality by preventing contamination and achieving regulatory compliance. This blog explores how environmental monitoring improves pharmaceutical product quality, with practical insights.
  • GMP, GxP